Results 51 to 60 of about 301,296 (304)

Incidence of venous thromboembolism following fracture or surgery.

, 2022
Timing of Venous Thromboembolism following a foot and ankle fracture. Nearly half of venous thromboembolism (49.8%) occurred within the first three weeks.
Michael J. Gouzoulis (13989663), Alexander J. Kammien (13989669), Brad Yoo (13989675), William M. McLaughlin (13989672), Peter Y. Joo (13989666), Jonathan N. Grauer (9389338)   +5 more
core   +1 more source

THSD7A Exacerbates Atherosclerosis via Activation of Signaling Axis αvβ3/CEBPD/IL1A

Advanced Science, EarlyView.
THSD7A exerts pro‐inflammatory effects and exacerbates atherosclerosis. Mechanistically, THSD7A regulates endothelial cell inflammation and atherosclerosis by activating the αvβ3/CEBPD/IL1A signaling axis. THSD7A is not only a genetic marker but also a potential therapeutic target for coronary artery disease (CAD).
Jiankun Liu, Hongfei Liu, Yiqi Wan, Andong Wu, Jiayu Qiu, Xueting Gong, Ya Zhao, Yuanyuan Li, Bingbing Zhou, Yangyi Zheng, Fang Wu, Yuanzheng Zhu, Weixin Lv, Xueer Li, Qiang Yuan, Xiao‐Li Tian   +15 more
wiley   +1 more source

The use of imaging in the diagnosis and treatment of thromboembolic pulmonary hypertension

Cardiology Journal
Chronic thromboembolic pulmonary hypertension (CTEPH) is a potentially life-threatening condition, classified as group 4 pulmonary hypertension (PH), caused by stenosis or occlusion of the pulmonary arteries due to unresolved thromboembolic material. The
Konstantin Szewczuk, Olga Dzikowska-Diduch, Marek Gołębiowski   +2 more
doaj   +1 more source

Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism

Haematologica, 2016
Venous thromboembolism occurs frequently in cancer patients. Two variants in the factor 5 gene (F5), rs6025 encoding for the factor V Leiden mutation R506Q, and rs4524 encoding K858R, have been found to be associated with venous thromboembolism.
Olga V. Gran, Erin N. Smith, Sigrid K. Brækkan, Hilde Jensvoll, Terry Solomon, Kristian Hindberg, Tom Wilsgaard, Frits R. Rosendaal, Kelly A. Frazer, John-Bjarne Hansen   +9 more
doaj   +1 more source

Treatment of venous thromboembolism [PDF]

Journal of Thrombosis and Haemostasis, 2005
This review on the treatment of patients with venous thromboembolic disease consists of three sections. The first section describes the epidemiology, natural history and reasons for treatment of venous thromboembolism (VTE), as well as a short overview on the evaluation of the use of antithrombotic agents and the spectrum of treatment options.
Buller, H. R., Sohne, M., Middeldorp, S.
openaire   +3 more sources

Upadacitinib Restrains the Pathogenic Fitness of CD4+ T Cells and Aberrant B Cell Programming in Optic Neuritis

Advanced Science, EarlyView.
Single‐cell profiling and functional perturbation reveal coordinated JAK1‐pSTAT3 downstream programs in optic neuritis, including MCL1‐dependent fitness of pathogenic CD4+ Tem cells and glycolysis‐linked, cholesterol‐sensitive B‐cell responses associated with RORA. Upadacitinib disrupts this reciprocal T‐B‐cell circuit and alleviates neuroinflammation,
Gengchen Jiang, Qi Jiang, Lian Han, Yue Peng, Xingyu Liu, Tong Yang, Hao Huang, Jiaying Liu, Yuan Gao, Hui Yang, Wenjun Zou, Zhaohuai Li, Wenru Su   +12 more
wiley   +1 more source

Therapeutic Management of Septic Venous Thrombosis: A Narrative Review

Infectious Disease Reports
Background/Objectives: Septic venous thrombosis is an uncommon complication but clinically significant due to its high morbidity and mortality and the complexity of therapeutic decision-making. The lack of standardized guidelines and the scarcity of high-
Anabel Franco-Moreno, Ana Bustamante-Fermosel, Juan Torres-Macho, Belén Comeche-Fernández   +3 more
doaj   +1 more source

High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromsø study

Haematologica, 2011
Background High-sensitivity C-reactive protein is associated with risk of arterial cardiovascular disease but conflicting results have been reported on its role in venous thromboembolic disease.
Erin M. Hald, Sigrid K. Brækkan, Ellisiv B. Mathiesen, Inger Njølstad, Tom Wilsgaard, Jan Brox, John-Bjarne Hansen   +6 more
doaj   +1 more source

Forty-One-Year-Old Man with Pulmonary Embolism 5 Months After COVID-19

Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 2021
Background: Hypercoagulation is one of the striking features of COVID-19. Patients hospitalized with COVID-19 are at high risk for venous thromboembolism. However, it is unknown if the risk for venous thromboembolism persists after discharge.
Muhanad Taha, Paul Nguyen, Aditi Sharma, Mazen Taha, Lobelia Samavati   +4 more
doaj   +1 more source

Venous thromboembolism in patients with gout and the impact of hospital admission, disease duration and urate-lowering therapy.

, 2019
BACKGROUND: Systemic inflammatory diseases have been associated with increased risk of venous thromboembolism. We aimed to quantify the risk of venous thromboembolism in patients with gout, the most common inflammatory arthritis, and to assess how ...
Roddy, E, Muller, S, Mallen, C, Clarson, L   +3 more
core   +1 more source